In the complement system, complement Factor H (CFH), a kind of soluble protein abundant in EVs of metastatic HCC cell lines that can inhibit the alternative complement pathway, is capable of reducing complement-mediated cell lysis. Here, CFH is linked to hepatocellular carcinoma.